Stay updated on Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications From PubMed description was updated to state that publications are automatically filled in from PubMed and may not all be about the study, and the page revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the operational status notice about government funding and NIH/Clinical Center status. The study details and other information on the page remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedTwo screenshots show the same ClinicalTrials.gov page with no core-content changes to eligibility, interventions, outcomes, or locations; only minor layout/presentation differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdated to v3.2.0 with a government operating status notice; removed v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now shows revision v3.0.2, replacing v3.0.1. The Back to Top element was removed as a minor UI adjustment.SummaryDifference0.2%

Stay in the know with updates to Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab with Nivolumab in Gastric Cancer Clinical Trial page.